Thus, JNK has been shown to promote the expression of some proteins responsible for extracellular matrix degradation during invasion in prostate cancer cells, such as matrix metalloproteinases (MMPs)-2 and -9, and urokinase-type plasminogen activator (u-PA) [56–58]. This evidence concerns the gene MAPK8 and prostate carcinoma.